Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuropharmacology of Dexmedetomidine Through Trimodal Imaging
NCT05435560Phase 1Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexmedetomidine in Anesthesia (2 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Brain positron emission tomography imaging signals at 2 hours, Functional magnetic resonance imaging signals at 2 hours and 1 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT05435560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05435560.